Long-term results of a cardiovascular implantable electronic device wrapped with an expanded polytetrafluoroethylene sheet

The use of an expanded polytetrafluoroethylene (ePTFE) sheet wrapping device for patients with pacemaker contact dermatitis is still controversial. This study aimed to retrospectively investigate the occurrence rate of allergies and other complications after implantation of a cardiovascular implanta...

Full description

Saved in:
Bibliographic Details
Published in:Journal of artificial organs 2012-09, Vol.15 (3), p.244-249
Main Authors: Yashiro, Bun, Shoda, Morio, Tomizawa, Yasuko, Manaka, Tetsuyuki, Hagiwara, Nobuhisa
Format: Article
Language:English
Subjects:
Aged
Arrhythmias, Cardiac - therapy
Biomedical Engineering and Bioengineering
Cardiac Surgery
Defibrillators, Implantable - adverse effects
Female
Heart Failure - therapy
Humans
Male
Medicine
Medicine & Public Health
Middle Aged
Nephrology
Original Article
Pacemaker, Artificial - adverse effects
Polytetrafluoroethylene
Prosthesis-Related Infections - etiology
Retrospective Studies
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The use of an expanded polytetrafluoroethylene (ePTFE) sheet wrapping device for patients with pacemaker contact dermatitis is still controversial. This study aimed to retrospectively investigate the occurrence rate of allergies and other complications after implantation of a cardiovascular implantable electronic device (CIED) wrapped with an ePTFE sheet. A total of 4,497 procedures of CIED implantation were performed at our institution between January 1993 and April 2010. Among 19 patients who underwent implantation of an electronic cardiac device wrapped with an ePTFE sheet, device implantation was performed in 11 patients for secondary prevention of device contact sensitivity, in 7 patients for primary prevention of device contact sensitivity, and in 1 patient for avoiding over-sensing of myopotentials. During follow-up periods (mean 46 ± 34 months), there were no allergic or inflammatory reactions to components of the device or ePTFE itself. Among 11 patients with a device wrapped with an ePTFE sheet for secondary prevention, 5 patients completed device replacement due to battery depletion and 3 patients had infections from the device. Wrapping implantable devices with an ePTFE sheet is an effective way of preventing device sensitivity in patients who require CIED therapy. However, the risk of infection from the device should be taken into consideration.
ISSN:1434-7229
1619-0904
DOI:10.1007/s10047-012-0634-8